Mayport LLC’s Relay Therapeutics RLAY Stock Holding History

Mayport LLC’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-49,681	Closed	-$420K	–	140
2025 Q4	$420K	Hold	49,681	–	–	0.08%	68
2025 Q3	$259K	Buy	+49,681	New	+$189K	0.06%	89

Other funds holding RLAY

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Mayport LLC's RLAY Position: Q1 2026 in Review

Mayport LLC sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 49,681 shares — an estimated $420K sold.

Mayport LLC first reported a position in RLAY in Q3 2025 and held it in 2 quarters. The position peaked at $420K in Q4 2025. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

Mayport LLC reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
Mayport LLC sold 49,681 Relay Therapeutics shares in Q1 2026, an estimated $420K.
Mayport LLC first reported a position in Relay Therapeutics in Q3 2025 and held it in 2 quarters.
Mayport LLC's Relay Therapeutics position peaked at $420K in Q4 2025.
242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Mayport LLC's 13F filing for Q1 2026, filed 21 Apr 2026.